Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
Go back to Ligand Reports Fourth Quarter and Full Year 2023 Financial Results| ALDEYRA THERAPEUT (NASDAQ: ALDX) | Delayed: 2.05 +0.09 (4.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $8.19 | |||
| Open | $1.95 | 52 Week Low | $3.39 | |||
| Day High | $2.15 | P/E | N/A | |||
| Day Low | $1.95 | EPS | $0.00 | |||
| Volume | 1,687,200 | |||||
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 262.17 -12.71 (4.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $274.88 | 52 Week High | $139.79 | |||
| Open | $267.73 | 52 Week Low | $82.07 | |||
| Day High | $272.79 | P/E | 609.70 | |||
| Day Low | $245.00 | EPS | $0.43 | |||
| Volume | 819,480 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 115.48 +1.61 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.87 | 52 Week High | $65.46 | |||
| Open | $113.97 | 52 Week Low | $47.97 | |||
| Day High | $115.63 | P/E | 78.56 | |||
| Day Low | $113.00 | EPS | $1.47 | |||
| Volume | 10,467,645 | |||||
| (NASDAQ: TVTX) | Delayed: 55.11 -0.04 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.15 | 52 Week High | $ | |||
| Open | $56.20 | 52 Week Low | $ | |||
| Day High | $56.81 | P/E | N/A | |||
| Day Low | $55.00 | EPS | $ | |||
| Volume | 1,742,309 | |||||
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 32.37 +1.99 (6.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.38 | 52 Week High | $5.17 | |||
| Open | $30.52 | 52 Week Low | $0.94 | |||
| Day High | $32.90 | P/E | N/A | |||
| Day Low | $30.52 | EPS | $0.00 | |||
| Volume | 3,319,237 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 1,280,292 | |||||

